Cutler Group’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,080
Closed -$35K 1763
2023
Q4
$35K Sell
2,080
-2,720
-57% -$45.8K ﹤0.01% 741
2023
Q3
$40K Buy
4,800
+4,000
+500% +$33.3K ﹤0.01% 749
2023
Q2
$19K Buy
800
+300
+60% +$7.13K ﹤0.01% 839
2023
Q1
$7K Hold
500
﹤0.01% 1078
2022
Q4
$5K Hold
500
﹤0.01% 1436
2022
Q3
$2K Hold
500
﹤0.01% 1754
2022
Q2
$2K Sell
500
-5,637
-92% -$22.5K ﹤0.01% 1735
2022
Q1
$58K Buy
6,137
+4,717
+332% +$44.6K ﹤0.01% 991
2021
Q4
$26K Sell
1,420
-2,820
-67% -$51.6K ﹤0.01% 1405
2021
Q3
$141K Buy
4,240
+2,240
+112% +$74.5K 0.01% 820
2021
Q2
$77K Buy
+2,000
New +$77K ﹤0.01% 1087
2021
Q1
Sell
-1,249
Closed -$64K 2643
2020
Q4
$64K Buy
+1,249
New +$64K ﹤0.01% 918
2020
Q3
Sell
-6,600
Closed -$128K 2258
2020
Q2
$128K Buy
+6,600
New +$128K 0.01% 570
2020
Q1
Hold
0
2043
2019
Q4
Hold
0
2122
2019
Q3
Hold
0
2119
2019
Q2
Hold
0
2173
2019
Q1
Sell
-44
Closed 2168
2018
Q4
$0 Sell
44
-4,400
-99% ﹤0.01% 2170
2018
Q3
$24K Buy
4,444
+4,400
+10,000% +$23.8K ﹤0.01% 1126
2018
Q2
$0 Sell
44
-2,600
-98% ﹤0.01% 2247
2018
Q1
$37K Sell
2,644
-1,782
-40% -$24.9K ﹤0.01% 1037
2017
Q4
$36K Buy
4,426
+222
+5% +$1.81K ﹤0.01% 1208
2017
Q3
$49K Buy
4,204
+3,013
+253% +$35.1K ﹤0.01% 1268
2017
Q2
$11K Sell
1,191
-6,729
-85% -$62.1K ﹤0.01% 2109
2017
Q1
$92K Buy
7,920
+7,520
+1,880% +$87.4K ﹤0.01% 1189
2016
Q4
$1K Hold
400
﹤0.01% 2741
2016
Q3
$3K Hold
400
﹤0.01% 2501
2016
Q2
$2K Sell
400
-3,651
-90% -$18.3K ﹤0.01% 2609
2016
Q1
$34K Buy
4,051
+1,651
+69% +$13.9K ﹤0.01% 1489
2015
Q4
$28K Buy
+2,400
New +$28K ﹤0.01% 1695